vs
PREFORMED LINE PRODUCTS CO（PLPC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是PREFORMED LINE PRODUCTS CO的1.1倍（$197.9M vs $173.1M），REPLIGEN CORP净利率更高（6.7% vs 4.9%，领先1.8%），REPLIGEN CORP同比增速更快（13.6% vs 3.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $11.8M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 10.8%）
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PLPC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$173.1M
营收增速更快
RGEN
高出10.1%
3.6%
净利率更高
RGEN
高出1.8%
4.9%
自由现金流更多
RGEN
多$5.8M
$11.8M
两年增速更快
RGEN
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.1M | $197.9M |
| 净利润 | $8.4M | $13.3M |
| 毛利率 | 29.8% | 52.5% |
| 营业利润率 | 6.8% | 9.0% |
| 净利率 | 4.9% | 6.7% |
| 营收同比 | 3.6% | 13.6% |
| 净利润同比 | -19.3% | 143.9% |
| 每股收益（稀释后） | $1.72 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLPCRGEN
| Q4 25 | $173.1M | $197.9M | ||
| Q3 25 | $178.1M | $188.8M | ||
| Q2 25 | $169.6M | $182.4M | ||
| Q1 25 | $148.5M | $169.2M | ||
| Q4 24 | $167.1M | $174.1M | ||
| Q3 24 | $147.0M | $154.9M | ||
| Q2 24 | $138.7M | $154.1M | ||
| Q1 24 | $140.9M | $151.3M |
净利润PLPCRGEN
| Q4 25 | $8.4M | $13.3M | ||
| Q3 25 | $2.6M | $14.9M | ||
| Q2 25 | $12.7M | $14.9M | ||
| Q1 25 | $11.5M | $5.8M | ||
| Q4 24 | $10.5M | $-30.3M | ||
| Q3 24 | $7.7M | $-654.0K | ||
| Q2 24 | $9.4M | $3.3M | ||
| Q1 24 | $9.6M | $2.1M |
毛利率PLPCRGEN
| Q4 25 | 29.8% | 52.5% | ||
| Q3 25 | 29.7% | 53.2% | ||
| Q2 25 | 32.7% | 50.0% | ||
| Q1 25 | 32.8% | 53.6% | ||
| Q4 24 | 33.3% | 26.1% | ||
| Q3 24 | 31.1% | 50.0% | ||
| Q2 24 | 31.9% | 49.8% | ||
| Q1 24 | 31.3% | 49.5% |
营业利润率PLPCRGEN
| Q4 25 | 6.8% | 9.0% | ||
| Q3 25 | 7.4% | 8.9% | ||
| Q2 25 | 10.1% | 7.6% | ||
| Q1 25 | 8.8% | 3.9% | ||
| Q4 24 | 10.5% | -17.7% | ||
| Q3 24 | 7.1% | -5.1% | ||
| Q2 24 | 8.1% | 1.0% | ||
| Q1 24 | 8.2% | 1.3% |
净利率PLPCRGEN
| Q4 25 | 4.9% | 6.7% | ||
| Q3 25 | 1.5% | 7.9% | ||
| Q2 25 | 7.5% | 8.2% | ||
| Q1 25 | 7.8% | 3.4% | ||
| Q4 24 | 6.3% | -17.4% | ||
| Q3 24 | 5.2% | -0.4% | ||
| Q2 24 | 6.8% | 2.2% | ||
| Q1 24 | 6.8% | 1.4% |
每股收益（稀释后）PLPCRGEN
| Q4 25 | $1.72 | $0.24 | ||
| Q3 25 | $0.53 | $0.26 | ||
| Q2 25 | $2.56 | $0.26 | ||
| Q1 25 | $2.33 | $0.10 | ||
| Q4 24 | $2.13 | $-0.55 | ||
| Q3 24 | $1.54 | $-0.01 | ||
| Q2 24 | $1.89 | $0.06 | ||
| Q1 24 | $1.94 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $38.3M | $542.2M |
| 股东权益账面价值 | $475.5M | $2.1B |
| 总资产 | $653.6M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.08× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PLPCRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务PLPCRGEN
| Q4 25 | $38.3M | $542.2M | ||
| Q3 25 | $36.0M | $537.9M | ||
| Q2 25 | $31.8M | — | ||
| Q1 25 | $29.1M | — | ||
| Q4 24 | $20.8M | $525.6M | ||
| Q3 24 | $27.2M | — | ||
| Q2 24 | $31.6M | — | ||
| Q1 24 | $55.0M | — |
股东权益PLPCRGEN
| Q4 25 | $475.5M | $2.1B | ||
| Q3 25 | $466.3M | $2.1B | ||
| Q2 25 | $460.7M | $2.1B | ||
| Q1 25 | $435.8M | $2.0B | ||
| Q4 24 | $422.3M | $2.0B | ||
| Q3 24 | $429.0M | $2.0B | ||
| Q2 24 | $416.2M | $2.0B | ||
| Q1 24 | $413.4M | $2.0B |
总资产PLPCRGEN
| Q4 25 | $653.6M | $2.9B | ||
| Q3 25 | $644.6M | $2.9B | ||
| Q2 25 | $631.5M | $2.9B | ||
| Q1 25 | $592.5M | $2.9B | ||
| Q4 24 | $573.9M | $2.8B | ||
| Q3 24 | $592.0M | $2.8B | ||
| Q2 24 | $572.6M | $2.9B | ||
| Q1 24 | $586.1M | $2.8B |
负债/权益比PLPCRGEN
| Q4 25 | 0.08× | 0.26× | ||
| Q3 25 | 0.08× | 0.26× | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.05× | 0.27× | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $11.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 6.8% | 8.9% |
| 资本支出强度资本支出/营收 | 5.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.60× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $33.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PLPCRGEN
| Q4 25 | $21.9M | $25.7M | ||
| Q3 25 | $18.9M | $48.1M | ||
| Q2 25 | $26.9M | $28.6M | ||
| Q1 25 | $5.7M | $15.0M | ||
| Q4 24 | $24.1M | $39.2M | ||
| Q3 24 | $9.4M | $49.3M | ||
| Q2 24 | $28.3M | $42.2M | ||
| Q1 24 | $5.8M | $44.7M |
自由现金流PLPCRGEN
| Q4 25 | $11.8M | $17.6M | ||
| Q3 25 | $8.3M | $43.4M | ||
| Q2 25 | $18.6M | $21.5M | ||
| Q1 25 | $-5.3M | $11.4M | ||
| Q4 24 | $20.6M | $33.6M | ||
| Q3 24 | $5.8M | $42.3M | ||
| Q2 24 | $24.6M | $37.4M | ||
| Q1 24 | $1.8M | $36.4M |
自由现金流率PLPCRGEN
| Q4 25 | 6.8% | 8.9% | ||
| Q3 25 | 4.7% | 23.0% | ||
| Q2 25 | 10.9% | 11.8% | ||
| Q1 25 | -3.6% | 6.8% | ||
| Q4 24 | 12.3% | 19.3% | ||
| Q3 24 | 3.9% | 27.3% | ||
| Q2 24 | 17.7% | 24.3% | ||
| Q1 24 | 1.3% | 24.0% |
资本支出强度PLPCRGEN
| Q4 25 | 5.9% | 4.1% | ||
| Q3 25 | 6.0% | 2.5% | ||
| Q2 25 | 4.9% | 3.9% | ||
| Q1 25 | 7.4% | 2.1% | ||
| Q4 24 | 2.1% | 3.2% | ||
| Q3 24 | 2.4% | 4.5% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 2.8% | 5.5% |
现金转化率PLPCRGEN
| Q4 25 | 2.60× | 1.93× | ||
| Q3 25 | 7.21× | 3.23× | ||
| Q2 25 | 2.12× | 1.92× | ||
| Q1 25 | 0.49× | 2.57× | ||
| Q4 24 | 2.30× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 3.02× | 12.70× | ||
| Q1 24 | 0.60× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
